MedTrace Logo

Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis

NCT02130648 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2014-12-31

No results posted yet for this study

Summary

The purprose of this study is to develop and validate an analytical and clinical NIPD test for cystic fibrosis from maternal blood by analysis circulating free fetal DNA (cff-DNA), searching for the paternal mutation in families with CFTR compound heterozygosity

Conditions

  • Noninvasive Mucinous Cystadenocarcinoma of Ovary

Interventions

OTHER

A sampling of blood

A sampling of blood de 14 ml

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Mireille CLAUSTRES · Laboratoire de Genetique Moleculaire Institut de Recherche Clinique INSERM 827 640, avenue du Doyen giraud 34295 MONTPELLIER cedex 5

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-07-31
Completion
2016-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02130648 on ClinicalTrials.gov